Success Stories: A Postdoctoral Fellow in Molecular Biology Finds Support Through North America Immigration Law Group and Gets His NIW Approved

 

Client’s Testimonial:

“Thank you so much! This is great.”


On August 11th, 2021, we received another EB-2 NIW (National Interest Waiver) approval for a Postdoctoral Research Fellow in the Field of Molecular Biology (Approval Notice).


General Field: Molecular Biology

Position at the Time of Case Filing: Postdoctoral Research Fellow

Country of Origin: Kazakhstan

State of Residence at the Time of Filing: Texas

Approval Notice Date: August 11th, 2021

Processing Time: 10 months, 20 days


Case Summary:

A postdoctoral research fellow from Kazakhstan working in the field of molecular biology approached us to help him with his NIW (National Interest Waiver) petition. So after extensive research when our team found that his proposed endeavor is of great importance as it aims to identify the mechanisms involved in conditions like cardiovascular disease, we countersigned the retainer agreement. Cardiovascular disease is one of the most significant threats to public health in the world. It is the most common cause of death, and according to the World Health Organization, it is responsible for around 17.9 million deaths per year. Through his research, he has identified specific compounds that improve markers for cardiovascular health. His work is thus vital for the development of effective preventive diets for patients predisposed to cardiovascular disease.

We went ahead and made a note of the following for his petition packet:

  • In recognition of the value and importance of his work, it has been granted funding by the United Kingdom’s Food Standards Agency, and GlaxoSmithKline. These organizations are devoted to the advancement of public health and scientific research for national interests, and funding from these institutions is incredibly competitive. These grants are reserved for research that has been recognized for its high scientific caliber and that addresses critical practical problems. This funding from the Food Standards Agency, and GlaxoSmithKline, therefore, demonstrates the significance and national importance of his research.
  • His research has also resulted in 8 peer-reviewed journal articles (2 of them first-authored) and 10 first-authored peer-reviewed conference papers. Moreover, these papers have been published in the top journals in the field, reflecting his peers’ recognition of the value of this research.
  • Not only has he successfully completed and published the results of his research, but his work has also gone on to influence his peers. That is, his publications have been cited a total of 346 times according to Google Scholar, thereby demonstrating that these publications are widely recognized and relied upon in the field of molecular biology.
We were thus without any reservations in representing him throughout the adjudication process. We are glad to have been of assistance to him in this journey and we wish him the very best in life.